Lipella Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $463.3K | $606.7K |
| FY2021 | — | $1.4M | $1.4M |
| FY2022 | — | $4.7M | $5.1M |
| FY2023 | — | $3.1M | $3.3M |
| FY2024 | — | $1.9M | $2.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $463.3K | $606.7K |
| FY2021 | — | $1.4M | $1.4M |
| FY2022 | — | $4.7M | $5.1M |
| FY2023 | — | $3.1M | $3.3M |
| FY2024 | — | $1.9M | $2.2M |